Search Results - "Aziz Kalantari, Bagher"

Rhenium Perrhenate ( 188 ReO 4 ) Induced Apoptosis and Reduced Cancerous Phenotype in Liver Cancer Cells by Asadian, Samieh, Piryaei, Abbas, Gheibi, Nematollah, Aziz Kalantari, Bagher, Reza Davarpanah, Mohamad, Azad, Mehdi, Kapustina, Valentina, Alikhani, Mehdi, Moghbeli Nejad, Sahar, Keshavarz Alikhani, Hani, Mohamadi, Morteza, Shpichka, Anastasia, Timashev, Peter, Hassan, Moustapha, Vosough, Massoud

“…Recurrence in hepatocellular carcinoma (HCC) after conventional treatments is a crucial challenge. Despite the promising progress in advanced targeted…”
Get full text

188Rhenium Treatment Induces DACT2 Expression in Hepatocellular Carcinoma Cells by Asadian, Samieh, Piryaei, Abbas, Farzaneh, Zahra, Bagher Aziz Kalantari, Azad, Mehdi, Sahar Moghbeli Nejad, Davarpanah, Mohamad Reza, Mohamadi, Morteza, Shpichka, Anastasia, Gheibi, Nematolah, Timashev, Peter, Vosough, Massoud

“…Objectives: Epigenetic alterations, including any change in DNA methylation pattern, could be the missing link of understanding radiation-induced genomic…”
Get full text

[68 Ga]Ga-CXCR4 PET/CT imaging in high-grade glioma for assessment of CXCR4 receptor expression by Roustaei, Hessamoddin, Vosoughi, Habibeh, Askari, Emran, Aziz Kalantari, Bagher, Norouzbeigi, Nasim, Anvari, Kazem, Beheshti, Mohsen, Aryana, Kamran

“…Gliomas account for 75 % of primary malignant CNS tumors. High-grade glioma (CNS WHO grades 3 and 4) have an unfavorable treatment response and poor outcome…”
Get full text

Correction: Asadian et al. Rhenium Perrhenate ( 188 ReO4) Induced Apoptosis and Reduced Cancerous Phenotype in Liver Cancer Cells. Cells 2022, 11 , 305 by Asadian, Samieh, Piryaei, Abbas, Gheibi, Nematollah, Aziz Kalantari, Bagher, Reza Davarpanah, Mohamad, Azad, Mehdi, Kapustina, Valentina, Alikhani, Mehdi, Moghbeli Nejad, Sahar, Keshavarz Alikhani, Hani, Mohamadi, Morteza, Shpichka, Anastasia, Timashev, Peter, Hassan, Moustapha, Vosough, Massoud

“…In the original publication [...]…”
Get full text

β-radiating radionuclides in cancer treatment, novel insight into promising approach by Asadian, Samieh, Mirzaei, Hamed, Kalantari, Bagher Aziz, Davarpanah, Mohamad Reza, Mohamadi, Morteza, Shpichka, Anastasia, Nasehi, Leila, Es, Hamidreza Aboulkheyr, Timashev, Peter, Najimi, Mustapha, Gheibi, Nematollah, Hassan, Moustapha, Vosough, Massoud

“…[Display omitted] Targeted radionuclide therapy, known as molecular radiotherapy is a novel therapeutic module in cancer medicine. β-radiating radionuclides…”
Get full text

68 GaGa-CXCR4 PET/CT imaging in high-grade glioma for assessment of CXCR4 receptor expression by Roustaei, Hessamoddin, Vosoughi, Habibeh, Askari, Emran, Aziz Kalantari, Bagher, Norouzbeigi, Nasim, Anvari, Kazem, Beheshti, Mohsen, Aryana, Kamran

“…Gliomas account for 75 % of primary malignant CNS tumors. High-grade glioma (CNS WHO grades 3 and 4) have an unfavorable treatment response and poor outcome…”
Get full text

Phase 2 study of a high dose of 186Re-HEDP for bone pain palliation in patients with widespread skeletal metastases by Pirayesh, Elahe, Amoui, Mahasti, Mirzaee, Hamid Reza, Tabei, Faraj, Rakhsha, Afshin, Kalantari, Bagher Aziz, Shafiei, Babak, Assadi, Majid, Asli, Isa Neshandar

“…(186)Re-1-hydroxyethylidene-1,1-diphosphonate (HEDP) is an attractive radiopharmaceutical for the treatment of bone pain arising from skeletal metastatic…”
Get full text